ArticleInternational journal of biomedical and clinical analysis2024
Protective Role of Quercetin on Silver Nanoparticle-Induced Hepatotoxicity in Sprague-Dawley Rats.
Article in International journal of biomedical and clinical analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Silver nanoparticles (Ag-NPs) are one of the most commercially used nanomaterials. However, their extensive usage has adverse biological effects, which has led to increasing concerns about their potential impact on human health and the environment. This study aimed to confirm Ag-NP-induced hepatotoxicity and determine the potential protective role of quercetin (Qur) in Ag-NP-induced hepatotoxicity. Fifteen healthy male Sprague-Dawley rats were divided into three group: (1) Control group (administered deionized water), (2) Ag-NPs group (administered 100 mg/Kg Ag-NP orally) and (3) Ag-NP+Qur group (administered 100 mg/Kg Ag-NPs+100 μl of Qur) for five consecutive days. Samples were collected 24 h after the last treatment following standard protocols. The antioxidant activity of Qur against Ag-NP-induced toxicity was determined by measuring serum levels of various enzymes including Alanine Aminotransferases (ALT), Gamma-Glutamyl Transferases, (GGT), Alkaline Phosphatases (ALP), biomarkers of oxidative stress, Malondialdehyde (MDA), reduced glutathione (GSH) and examining liver histopathology. A significant increase in the activity of serum liver enzymes (ALT, ALP, GGT), MDA and alterations in liver morphology were noted in Ag-NPs treated rats relative to control rats. In contrast, reduced glutathione level was considerably lower in Ag-NPs treated rats compared to that in control rats. Co-administration of Qur resulted in significant changes in the biochemical parameters compared to that in Ag-NP-treated rats. The activity of liver enzymes, liver injury and oxidative stress biomarkers were found to be decreased, whereas levels of reduced glutathione were increased in the Qur+Ag-NP group. Our results suggest that the antioxidant Qur may have a protective role against Ag-NP-induced hepatotoxicity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.